本帖最后由 老马 于 2013-3-13 13:43 编辑
* p! d2 _, P: g9 x7 U0 Q; D- y* _; A* r- ?" D8 C/ S
健择（吉西他滨）+顺铂+阿瓦斯汀
3 k# w3 L y6 E; T Gemzar +Cisplatin + Avastin
* h, a/ D, f6 d( V$ Bhttp://annonc.oxfordjournals.org/content/21/9/1804.full
2 S# l$ B( D; y" b% l4 P- }- |Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
2 C+ _) P/ C2 | I( ]Patients and methods: Patients (n = 1043) received cisplatin 80 mg/m2 and gemcitabine 1250 mg/m2 for up to six cycles plus bevacizumab 7.5 mg/kg (n = 345), bevacizumab 15 mg/kg (n = 351) or placebo (n = 347) every 3 weeks until progression. Primary end point was progression-free survival (PFS); OS was a secondary end point.
! f" Q+ f/ c2 gResults: Significant PFS prolongation with bevacizumab compared with placebo was maintained with longer follow-up {hazard ratio (HR) [95% confidence interval (CI)] 0.75 (0.64–0.87), P = 0.0003 and 0.85 (0.73–1.00), P = 0.0456} for the 7.5 and 15 mg/kg groups, respectively. Median OS was >13 months in all treatment groups; nevertheless, OS was not significantly increased with bevacizumab [HR (95% CI) 0.93 (0.78–1.11), P = 0.420 and 1.03 (0.86–1.23), P = 0.761] for the 7.5 and 15 mg/kg groups, respectively, versus placebo. Most patients (62%) received multiple lines of poststudy treatment. Updated safety results are consistent with those previously reported. * }+ o% P6 f! k$ I: B- a) ]; X
Cisplatin Gemzar Avastin.PDF
(329.84 KB, 下载次数: 627)
8 _; N) \! x) }/ S- ~' }6 T4 b
华为网盘附件：/ Z" x4 L' R+ E; b
【华为网盘】ava.JPG
) L$ T& @% D2 N% ^ |
肺癌历经手术-复发-脑转移，如今母亲
讲述者：一只阿狸整理者：pear
熟悉我家的朋友都知道，我母亲虽然是IB期肺癌，但是很
20位专家、12场直播，详解肺癌患者最
作者：雨过天晴近年来，免疫治疗作为肿瘤治疗领域的重大突破，正在逐步改写肺癌患者的
67岁父亲肺腺癌4A期 L858R-伏美替尼
病情：
24年4月底我父亲因为呼吸不畅就医，抽胸水、做穿刺活检、做基因检测，结论
急急急，求方案，希望得到大家的帮助
群里的老师们，请问如果肾转移会左侧腰以上痛吗？已经痛了有半个多月。一开始痛的时候
21突变 特罗凯5年5个月后奥西不到一
Hi 各位，
求助
基本情况：女 64岁 无吸烟史，
2018年确诊，右肺切除术后，当时分期
显身卡
